Featured Research

from universities, journals, and other organizations

HIV/ADIS Program, AMPATH, Successful In Restoring Lives Not Just Immune Systems

Date:
November 29, 2007
Source:
Indiana University
Summary:
The HIV/AIDS epidemic in Sub-Saharan Africa is decimating populations, depressing economies, deepening poverty and destabilizing traditional social orders. Various programs to prevent and treat HIV/AIDS have been developed, but few have demonstrated the capacity to make an on-going difference to a large number of affected individuals, their families and their communities. A program which broadly defines health care is successful in fighting AIDS and improving lives in sub-Saharan Africa.

AMPATH staffers harvest produce for HIV patients and their families in Kenya.
Credit: Photo by Tyagan Miller, Copyright Indiana University

The HIV/AIDS epidemic in Sub-Saharan Africa is decimating populations, depressing economies, deepening poverty and destabilizing traditional social orders. Various programs to prevent and treat HIV/AIDS have been developed, but few have demonstrated the capacity to make an on-going difference to a large number of affected individuals, their families and their communities.

Related Articles


A study published in the December issue of the Journal of General Internal Medicine reports on why AMPATH, a program which broadly defines health care, is successful in fighting AIDS and improving lives.

AMPATH, which stands for the Academic Model for the Prevention and Treatment of HIV/AIDS, was initiated in 2001 and grew out of a long-standing partnership between the Indiana University School of Medicine, Moi University and Moi Teaching and Referral Hospital, both in Eldoret, Kenya.

The first AMPATH patient was enrolled 6 years ago; today AMPATH serves an estimated 52,000 HIV-positive people in western Kenya.

"If we think that we can succeed in treating people with HIV/AIDS without attending to all their needs, we are mistaken," said Thomas Inui, M.D., M.S., principal investigator of the JGIM study. "The story of AMPATH is the story of attention to health and to restoring lives, not just immune systems." Dr. Inui is president and CEO of the Regenstrief Institute, Inc., Sam Regenstrief Professor of Health Services Research and associate dean for health care research at the Indiana University School of Medicine.

AMPATH takes a comprehensive approach to HIV/AIDS, attending to medical care, nutritional sufficiency and economic security. It assisting patients and their families by providing education, preventive services, treatment, dietary assistance, and by helping them grow food and hold jobs. Once individuals with HIV/AIDS are able to again earn a living and become vital members of their community once again, even the stigma associated with HIV/AIDS disappears.

Today AMPATH has expanded to include a consortium of U.S. medical schools led by the IU School of Medicine. Patient enrollment is rising by 2000 per month. AMPATH's high-production farms and demonstration farms provide food assistance to up to 30,000 people every month.

For the JGIM study, Dr. Inui and colleagues conducted oral interviews with individuals involved in AMPATH -- Kenyan physicians, clinical officers (similar to physicians' assistants in the U.S.), nurses, nutritionists, pharmacists and others working within facilities operated by the Kenya Ministry of Health. The interviews demonstrate how these individuals go beyond humane and compassion treatment.

Initially, health personnel were aware that families frequently walked for hours or even days, sometimes pushing a wheelbarrow as a means to transport a loved one, to a clinic. It was apparent that unless the doctors and healthcare workers could ensure continued nourishment to the patients and means for the families to survive economically, there would be no return to health. From this need grew educational and vocational programs for patients and their families and the farms to provide both crops and training and ultimately health (half the patients are on anti-retroviral drugs) and income security.

In addition to Dr. Inui, co-authors of the JGIM study, which was funded by the Purpleville Foundation of Ontario, Canada, are Winston M. Nyandiko, M.D., and Sylvester N. Kimaiyo, M.D., of Moi University School of Medicine, Tadeo Muriuki, B.S., of AMPATH, Richard M. Frankel, Ph.D., Joseph J. Mamlin, M.D., Robert M. Einterz, M.D., and John E. Sidle, M.D., of the Indiana University School of Medicine. Dr. Frankel is also affiliated with the Richard Roudebush VA Medical Center in Indianapolis.


Story Source:

The above story is based on materials provided by Indiana University. Note: Materials may be edited for content and length.


Cite This Page:

Indiana University. "HIV/ADIS Program, AMPATH, Successful In Restoring Lives Not Just Immune Systems." ScienceDaily. ScienceDaily, 29 November 2007. <www.sciencedaily.com/releases/2007/11/071126110449.htm>.
Indiana University. (2007, November 29). HIV/ADIS Program, AMPATH, Successful In Restoring Lives Not Just Immune Systems. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2007/11/071126110449.htm
Indiana University. "HIV/ADIS Program, AMPATH, Successful In Restoring Lives Not Just Immune Systems." ScienceDaily. www.sciencedaily.com/releases/2007/11/071126110449.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins